Nov 17, 2026

Events

Join Prescient at ASH 2026

12–15 December 2026 | New Orleans, USA

Making sense of hematology at ASH

The ASH Annual Meeting is the largest hematology meeting in the world. Tens of thousands of clinicians, researchers and industry professionals come together to share new science across malignant and classical hematology. For biopharma teams, it’s one of the best places to see how fresh data is changing treatment paradigms, competitive dynamics and future opportunities.

At this year’s congress, Prescient is looking forward to engaging with the latest clinical data, evolving scientific narratives and shifts across the hematology landscape.

With thousands of abstracts, oral presentations and posters, the hard part isn’t getting hold of the information. It’s working out what matters most and what to do about it. We work with hematology and oncology teams to interpret the evidence, understand the implications and agree clear next steps.


Focus at ASH 2026

During ASH, our team will be following developments across hematology, including late-breaking data, changing treatment sequencing and new areas of scientific and commercial interest. We’ll be looking at how these developments could affect the competitive environment, and what they might mean for future clinical, development and commercial decisions.


Our hematology experience

Prescient has supported hematology and oncology teams with a wide range of strategic and evidence-based questions, from early development through to commercialization.

  • 1,700+ oncology projects delivered, including lymphoma and multiple myeloma
  • 390+ rare disease projects delivered, including hemophilia and sickle cell disease
  • 630+ assets supported across life sciences
  • 5,000+ projects delivered globally

Our work covers malignant hematology as well as non-malignant conditions such as hemophilia, bleeding disorders and sickle cell disease. Across scientific insight, strategy and stakeholder perspectives, we support teams at every stage of the asset lifecycle.


Meet us at ASH

Our team will be on-site throughout ASH 2026, with experience across hematology strategy, evidence generation and commercial decision-making. We’d welcome the chance to discuss the latest data from the congress and what it could mean for your assets, portfolio or strategic priorities.

Meet Prescient at ASH 2026

We’ll be on-site at ASH to discuss the latest hematology data and what it means for your portfolio.
Book a meeting
Meet Prescient at ASH 2026

Get in Touch

Reach out to explore how we can
support your goals

If you're interested in learning more about our services or would like to speak with the team, please get in touch.

Contact us